News
I was 21 and the message couldn't have been clearer: it was all downhill for me now. I'd soon look like an old lady. Much ...
Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...
1h
Investor's Business Daily on MSNApogee Reverses Lower Despite Promise For Twice-Yearly Eczema ShotApogee Therapeutics shares crumbled Monday despite promising results for what could become a quarterly or twice-yearly shot ...
Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...
Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...
2h
InvestorsHub on MSNApogee Therapeutics Shares Surge After Promising Eczema Drug Trial ResultsShares of Apogee Therapeutics Inc. (NASDAQ:APGE) soared 24% in Monday’s session following encouraging results from its Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results